Finance Watch: Three New Biopharma IPOs In The US With Eight More Entering The Queue

Eight biopharmaceutical companies went public in the US during May with mixed results – including mid-month initial public offerings from Applied Therapeutics Inc., Bicycle Therapeutics Ltd. and IDEAYA Biosciences Inc. – and eight more companies indicated their IPO aspirations in recent weeks.

Five drug developers launched first-time offerings on 7 and 8 May, followed by Applied Therapeutics, Bicycle and IDEAYA. The offerings bring the year's total to 21 biopharma IPOs in the US. The eight offerings in May more than double the monthly average of about three biopharma IPOs per month for the January-to-April period when 13 companies went public